AbCellera discovers antibodies and develops them with pharmaceutical, biotechnology and nonprofit partners. It last closed at $11.03 on Nov 17, down 0.81% on the day. ABCL last reported earnings on Mon, Nov 9, 2026. The average 12-month price target from 6 analysts is $16.17 (+46.6% from the last close), with a high of $20.00 and a low of $13.00. Analyst consensus is Strong Buy, based on the latest ratings from 6 firms (5 buy, 1 hold, 0 sell). Over the past 90 days StreetAlpha recorded 1 whale options trade in ABCL, 100% of them bullish and 0% bearish.
Each firm's latest rating on ABCL in the past 90 days
Average 12-month target
$16.17
▲ 46.6% upside
Based on 6 analysts who set a price target on ABCL in the past 90 days. The average target is $16.17, with a high of $20.00 and a low of $13.00, compared with the last close of $11.03.
Highest target$20.00
Average target$16.17
Lowest target$13.00
Latest rating changes
Piper SandlerMaintained
Nov 16Buy$20
StoneXMaintained
Nov 11Buy$15
StifelTarget raised
Nov 10Buy$9 → $14
UBSInitiated
Oct 12Buy$18
JP MorganInitiated
Sep 29Buy$17
Date
Firm
Action
Rating
Price target
Nov 16
Piper Sandler
Maintained
Buy
$20
Nov 11
StoneX
Maintained
Buy
$15
Nov 10
Stifel
Target raised
Buy
$9 → $14
Oct 12
UBS
Initiated
Buy
$18
Sep 29
JP Morgan
Initiated
Buy
$17
Loading…
Technical Analysis
ABCL · as of the Nov 17 close · updated after every close
Pullback inside a longer uptrend
The stock is 9% below its 20 day and 12% below its 50 day average. It is 34% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 42). The nearest support is the swing low (Sep 2) at $10.80, and the nearest resistance the Pivot at $11.08.
Short trendBearish
Long trendBullish
MomentumWeak
StretchNormal
VolatilityHigh, 8.0%/day
Key levels
$15.0252 week high+36.2%
$12.3250 day average+11.7%
$12.0020 day average+8.8%
$11.82Swing high (Sep 3)+7.2%
$11.35Pivot R1+2.9%
$11.08Pivot+0.5%
$11.03Last close
$10.80Swing low (Sep 2)−2.1%
$10.76Pivot S1−2.4%
$10.41100 day average−5.6%
$7.31200 day average−33.7%
$2.7552 week low−75.1%
Indicators
RSI (14)
42.26
Middle of its range
Neutral
MACD
-0.25
Below its signal line
Bearish
Stochastic
14.6
Near the bottom of its range
Oversold
ADX (14)
12.4
No clear trend
Williams %R
-91.3
Oversold below −80, overbought above −20
Oversold
CCI (20)
-122.8
Oversold below −100, overbought above 100
Oversold
Rate of change
−9.4%
Change over 10 sessions
Bearish
ATR (14)
$0.89
Typical daily range, 8.1% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Above
MA 200Above
Rising
Short trendBullish
Long trendNot enough history
MomentumNeutral
StretchNormal
VolatilityNormal, 14.0%/day
Key levels
$15.0252 week high+36.2%
$12.3250 day average+11.7%
$12.0020 day average+8.8%
$11.82Swing high (Sep 3)+7.2%
$11.35Pivot R1+2.9%
$11.08Pivot+0.5%
$11.03Last close
$10.80Swing low (Sep 2)−2.1%
$10.76Pivot S1−2.4%
$10.41100 day average−5.6%
$7.31200 day average−33.7%
$2.7552 week low−75.1%
Indicators
RSI (14)
57.60
Middle of its range
Neutral
MACD
1.54
Below its signal line
Bearish
Stochastic
42.9
Middle of its range
Neutral
ADX (14)
43.0
Strong uptrend
Williams %R
-84.9
Oversold below −80, overbought above −20
Oversold
CCI (20)
19.6
Oversold below −100, overbought above 100
Neutral
Rate of change
+1.3%
Change over 10 sessions
Bullish
ATR (14)
$1.54
Typical daily range, 13.9% of price
MA 10Below
MA 20Above
MA 50Above
MA 100Above
MA 200–
What happened before, for ABCL
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how ABCL did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow ABCL usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How ABCL has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2020.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ABCL is in one of them and how their past ABCL trades turned out.
AbCellera is a biotechnology company based in Vancouver, British Columbia, Canada. It uses its antibody discovery and development platform to find antibodies that partners can turn into drug candidates. Its partners include pharmaceutical companies, biotechnology companies, and nonprofit and government organizations. AbCellera receives upfront payments for technology access and discovery research, and it may also receive milestone payments and royalties if partner drugs advance or sell.